108 NoTES To ThE FINANCIAL STATEMENTS 1 opERATINg pRoFIT Operating profit includes the following items: oTHER opERATINg INComE ANd ExpENSE 2008 2007 2006 $m $m $m 1 Royalties 113 236 327 Net gain on disposal of property, plant and equipment 6 9 2 Net loss on disposal of intangible assets 17 1 1 Gains on divestments of non-core products 118 192 161 Other income 304 310 115 Other expense 18 80 Other operating income and expense 524 728 524 1 Royalty income is net of amortisation of intangible assets relating to royalty income streams and in 2008 the impairment of the HPV royalty intangible asset $91m.
RESTRuCTuRINg ANd SyNERgy CoSTS During 2008 the Group continued the restructuring and synergy programmes announced in 2007.
In addition, the Group announced further programmes during the year.
The tables below show the costs that have been charged in respect of these programmes to the income statement by cost category and type.
Severance provisions are detailed in Note 18.
2008 2007 2006 $m $m $m Cost of sales 405 415 Research and development 166 73 Selling, general and administrative expenses 310 478 Total charge 881 966 2008 2007 2006 $m $m $m Severance costs 499 678 Accelerated depreciation and impairment 219 203 Other 163 85 Total charge 881 966 The total charge in respect of the Global Supply Chain productivity initiative is anticipated to be around $1,250m.
In aggregate, research and development restructuring costs of around $300m are expected.
The total charge in respect of selling and marketing and business infrastructure is anticipated to be around $1,400m.
2 FINANCE INComE ANd ExpENSE 2008 2007 2006 $m $m $m Finance income Returns on fixed deposits and equity securities 15 52 29 Returns on short-term deposits 127 298 330 Expected return on post-employment defined benefit plan assets 584 573 518 Fair value gains on debt, interest rate swaps and investments 128 36 11 Total finance income 854 959 888 Finance expense Interest on debt and commercial paper 664 513 59 Interest on overdrafts and other financing costs 50 9 13 Interest on post-employment defined benefit plan liabilities 589 539 475 Fair value charges on debt, interest rate swaps and investments 2 6 Net exchange losses 12 3 14 Total finance expense 1,317 1,070 561 Net finance expense income 463 111 327 ASTRAZENECA ANNuAl REpoRT ANd FoRm 20-F INFoRmATIoN 2008
